NO994806L - Peptidfragmenter av myelin basisprotein, deres farmasöytiske preparater og deres anvendelse for å behandle multippel sklerose - Google Patents

Peptidfragmenter av myelin basisprotein, deres farmasöytiske preparater og deres anvendelse for å behandle multippel sklerose

Info

Publication number
NO994806L
NO994806L NO994806A NO994806A NO994806L NO 994806 L NO994806 L NO 994806L NO 994806 A NO994806 A NO 994806A NO 994806 A NO994806 A NO 994806A NO 994806 L NO994806 L NO 994806L
Authority
NO
Norway
Prior art keywords
mbp
residues
levels
amino acid
synthetic peptides
Prior art date
Application number
NO994806A
Other languages
English (en)
Other versions
NO994806D0 (no
NO325018B1 (no
Inventor
Kenneth G Warren
Ingrid Catz
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Publication of NO994806D0 publication Critical patent/NO994806D0/no
Publication of NO994806L publication Critical patent/NO994806L/no
Publication of NO325018B1 publication Critical patent/NO325018B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO19994806A 1997-04-04 1999-10-01 Anvendelse av et peptid for fremstilling av et farmasoytisk preparat for behandling av multippel sklerose. NO325018B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2201841A CA2201841C (en) 1997-04-04 1997-04-04 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
PCT/CA1998/000290 WO1998045327A1 (en) 1997-04-04 1998-04-03 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis

Publications (3)

Publication Number Publication Date
NO994806D0 NO994806D0 (no) 1999-10-01
NO994806L true NO994806L (no) 1999-12-06
NO325018B1 NO325018B1 (no) 2008-01-14

Family

ID=4160340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994806A NO325018B1 (no) 1997-04-04 1999-10-01 Anvendelse av et peptid for fremstilling av et farmasoytisk preparat for behandling av multippel sklerose.

Country Status (20)

Country Link
EP (2) EP0970121B1 (no)
JP (1) JP4173557B2 (no)
AT (2) ATE400582T1 (no)
AU (1) AU751303B2 (no)
CA (2) CA2201841C (no)
CY (2) CY1107445T1 (no)
CZ (1) CZ299535B6 (no)
DE (2) DE69839163T2 (no)
DK (2) DK1394178T3 (no)
ES (2) ES2307317T3 (no)
HU (1) HU226768B1 (no)
NO (1) NO325018B1 (no)
NZ (1) NZ338091A (no)
PL (1) PL191965B1 (no)
PT (2) PT1394178E (no)
RO (1) RO119303B1 (no)
RU (1) RU2198893C2 (no)
SK (1) SK285815B6 (no)
UA (1) UA60331C2 (no)
WO (1) WO1998045327A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004536819A (ja) 2001-06-11 2004-12-09 トランジション・セラピューティックス・インコーポレーテッド ウイルス性、増殖性および炎症性の疾患の治療のためにビタミンｂ１２および治療薬を用いた複合治療
RU2261713C1 (ru) * 2004-04-27 2005-10-10 Государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства здравоохранения Российской Федерации" Способ лечения тяжелой формы острого оптического неврита у пациентов с рассеянным склерозом
EP2488196B1 (en) 2009-10-12 2015-12-16 LIFEBio Laboratories LLC Composition for treatment of multiple sclerosis
RU2646817C1 (ru) * 2016-12-27 2018-03-07 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Пептид из состава тяжелой цепи иммуноглобулина человека, пригодный для лечения рассеянного склероза

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2021611C1 (ru) * 1991-04-19 1994-10-15 Михайленко Анатолий Андреевич Способ диагностики рассеянного склероза
US5817629A (en) * 1991-10-22 1998-10-06 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
CA2053799C (en) * 1991-10-22 2002-03-12 Kenneth G. Warren Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid
CA2133749A1 (en) * 1992-04-09 1993-10-28 Howard L. Weiner Suppression of t-cell proliferation using peptide fragments of myelin basic protein
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
IL115766A0 (en) * 1994-10-25 1996-01-19 Immulogic Pharma Corp Composition and treatment for multiple sclerosis
US6329499B1 (en) * 1994-11-18 2001-12-11 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein

Also Published As

Publication number Publication date
CA2494338C (en) 2007-07-17
CZ299535B6 (cs) 2008-08-27
AU751303B2 (en) 2002-08-15
NO994806D0 (no) 1999-10-01
DE69839694D1 (de) 2008-08-21
RO119303B1 (ro) 2004-07-30
HU226768B1 (en) 2009-09-28
WO1998045327A1 (en) 1998-10-15
PL336085A1 (en) 2000-06-05
SK285815B6 (sk) 2007-08-02
ATE386941T1 (de) 2008-03-15
CY1107445T1 (el) 2012-12-19
UA60331C2 (uk) 2003-10-15
CA2201841A1 (en) 1998-10-04
EP0970121A1 (en) 2000-01-12
SK132999A3 (en) 2000-06-12
ES2307317T3 (es) 2008-11-16
CA2201841C (en) 2010-01-26
CZ9903464A3 (cs) 2000-11-15
HUP0000812A3 (en) 2000-10-30
CY1108239T1 (el) 2014-02-12
EP1394178A1 (en) 2004-03-03
ATE400582T1 (de) 2008-07-15
PT1394178E (pt) 2008-04-15
EP0970121B1 (en) 2008-07-09
PT970121E (pt) 2008-09-22
RU2198893C2 (ru) 2003-02-20
DK1394178T3 (da) 2008-05-26
NZ338091A (en) 2001-10-26
PL191965B1 (pl) 2006-07-31
NO325018B1 (no) 2008-01-14
DK0970121T3 (da) 2008-10-20
DE69839163D1 (de) 2008-04-03
JP2001518885A (ja) 2001-10-16
JP4173557B2 (ja) 2008-10-29
ES2299657T3 (es) 2008-06-01
EP1394178B1 (en) 2008-02-20
HUP0000812A2 (hu) 2000-09-28
CA2494338A1 (en) 1998-10-04
DE69839163T2 (de) 2009-02-12
AU6913098A (en) 1998-10-30
HK1063805A1 (en) 2005-01-14

Similar Documents

Publication Publication Date Title
NZ293910A (en) Peptides useful in immunoregulation of antibodies to human myelin basic protein, pharmaceutical compositions and method of treatment
ATE425181T1 (de) Therapeutische zusammensetzungen aus antikorper und antisens nukleinsäuren gegen serrate
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
AU2750092A (en) Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid
WO2002036614A3 (en) Peptides for use in the treatment of alzheimer's disease
CY1108239T1 (el) Θραυσματα πεπτιδιου της βασικης πρωτεϊνης της μυελινης, οι φαρμακευτικες τους συνθεσεις και η χρηση τους στη θεραπεια της σκληρυνσης κατα πλακας
WO1995030435A3 (en) Compositions and treatment for multiple sclerosis
IL90391A0 (en) Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them
NZ335835A (en) Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
EP0342015A3 (en) Peptides, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees